Related Experiment Video

Updated: Jul 21, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Mineralocorticoid receptor antagonism and cardiac remodeling in ischemic heart failure

D Fraccarollo1, P Galuppo, J Bauersachs

  • 1Medizinische Klinik der Julius-Maximilians-Universität, Würzburg, Germany.

Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|August 24, 2004
PubMed

Insights

Aldosterone antagonists significantly reduce mortality in heart failure patients by blocking aldosterone's harmful effects. These drugs improve cardiac remodeling and function, offering benefits beyond ACE inhibitors alone.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Background:

  • Elevated aldosterone levels post-myocardial infarction and in heart failure correlate with disease severity.
  • Aldosterone contributes to sodium/water retention, sympathoadrenergic activation, endothelial dysfunction, fibrosis, and hypertrophy.
  • Standard ACE inhibitor doses may not fully suppress aldosterone's effects.

Purpose of the Study:

  • To review clinical and experimental data on aldosterone antagonists in ischemic heart failure.
  • To emphasize the mechanisms by which these antagonists affect left ventricular remodeling and function.

Main Methods:

  • Review of clinical trial data (RALES, EPHESUS) and experimental studies.
  • Analysis of molecular and physiological effects of mineralocorticoid receptor antagonism.

Main Results:

  • Aldosterone receptor blockade markedly reduces mortality in heart failure patients.
  • Key mechanisms include reduced cardiac fibrosis, regression of hypertrophy, improved endothelial function, and reduced oxidative stress.
  • Eplerenone combined with ACE inhibitors showed superior improvement in cardiac remodeling in rat models compared to ACE inhibitors alone.

Conclusions:

  • Aldosterone antagonists are crucial in managing heart failure, offering benefits beyond ACE inhibitors.
  • Reduced fibrosis is a primary mechanism, but other factors also contribute to improved cardiac outcomes.
  • Further research into aldosterone antagonism in ischemic heart failure is warranted.

More Related Videos

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...